Stock MAYBAKER MAY & BAKER NIGERIA PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company May & Baker Nigeria plc

Equities

MAYBAKER

NGMAYBAKER01

Pharmaceuticals

End-of-day quote Nigerian S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
6 NGN -.--% Intraday chart for May & Baker Nigeria plc -.--% +14.29%
Apr. 29 May & Baker Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Jan. 30 May & Baker Nigeria plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Business Summary

May and Baker Nigeria Plc is a diversified group organized around 2 areas of activity:

- manufacturing of pharmaceutical products and vaccines (99.8% of net sales);

- manufacturing and distribution of mineral water (0.2%): Lily brand.

All net sales are earned in Nigeria.

Number of employees: 364

Sales per Business

NGN in Million2022Weight2023Weight Delta
Pharmaceuticals
99.8 %
14,302 99.8 % 19,656 99.8 % +37.44%
Beverage
0.2 %
27 0.2 % 39 0.2 % +46.86%

Sales per region

NGN in Million2022Weight2023Weight Delta
Nigeria
100.0 %
14,328 100.0 % 19,695 100.0 % +37.46%

Managers

Managers TitleAgeSince
Patrick Ajah CEO
 Chief Executive Officer - 20-10-31
Ayodeji Aboderin DFI
 Director of Finance/CFO - 13-12-31
Godwin O. Obiakor CMP
 Compliance Officer - -

Members of the board

Members of the board TitleAgeSince
Valentine Okelu
- -
Edudie Abebe BRD
 Director/Board Member - 13-03-13
Ayodeji Aboderin DFI
 Director of Finance/CFO - 13-12-31
Samuel Onyishi BRD
 Director/Board Member - 19-03-20
Daisy Danjuma CHM
 Chairman 71 19-05-29
Patrick Ajah CEO
 Chief Executive Officer - 20-10-31
Kolawole Durojaiye BRD
 Director/Board Member - 21-06-02
Rahila Ilegbodu BRD
 Director/Board Member - 22-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,725,234,886 710,321,895 ( 41.17 %) 0 41.17 %

Company contact information

May & Baker Nigeria Plc

Industrial Estate 3/5 Sapara Street

100001, Lagos

+234 811 368 1447

http://www.may-baker.com
address May & Baker Nigeria plc(MAYBAKER)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6 NGN
Average target price
6.92 NGN
Spread / Average Target
+15.33%
Consensus

Sector Other Pharmaceuticals

1st Jan change Capi.
MAY & BAKER NIGERIA PLC Stock May & Baker Nigeria plc
+14.29% 7.45M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MAYBAKER Stock
  4. Company May & Baker Nigeria plc